To validate the method,
healthy volunteers underwent 6-
18F-fluorodopamine
scanning of the head, thorax, and abdomen,
with or without treatment with desipramine to block sympathoneural uptake of catecholamines.
13N-Ammonia scanning was used to address possible group differences
in 6-
18F-fluorodopamine delivery by blood perfusion.
Results: Desipramine treatment was associated with decreased 6-18F-fluorodopamine–derived radioactivity in the heart, renal cortex, and thyroid gland but not in the liver, spleen, renal pelvis, or salivary glands.
Both the PD+OH group and the PAF group had decreased 6-
18F-fluorodopamine–derived
radioactivity in the heart (
P <> (
P = 0.02 and
P = 0.005, respectively). The PD+OH group also
had decreased radioactivity in the thyroid gland (
P = 0.01).
Neither group had decreased radioactivity in the other organs,
after correction for
13N-ammonia–derived radioactivity.
Conclusion: 6-
18F-Fluorodopamine scanning visualizes sympathetic
innervation in the heart, renal cortex, and thyroid gland.
Both PD+OH and PAF involve decreased noradrenergic innervation that is most prominent in the heart but is also detectable in extracardiac organs.
Dnyanesh N. Tipre, MPharm, PhD and David S. Goldstein, MD, PhD Clinical Neurocardiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland
JNM 2005 46